Search results
-
Immunogenicity is a major problem with protein-based therapeutics due to circulating anti-drug...
Immunogenicity is a major problem with protein-based therapeutics due to circulating anti-drug antibody (ADA) production. ADA may lead to many clinical problems including allergic reactions, altered pharmacokinetic, reduced efficacy, etc.- thomasrsharkey
- Profile post